Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
María Haro, Joseph
Novick, Diego
Belger, Mark
and
Jones, Peter B.
2006.
Tipo de antipsicótico y correlatos de la interrupción del tratamiento de antipsicóticos en el tratamiento ambulatorio de la esquizofrenia.
European psychiatry (Ed. Española),
Vol. 13,
Issue. 5,
p.
236.
Schmitt, L.
and
Cailhol, L.
2007.
Discussion.
L'Encéphale,
Vol. 33,
Issue. ,
p.
81.
Wehmeier, Peter M.
Kluge, Michael
Schneider, Edith
Schacht, Alexander
Wagner, Thomas
and
Schreiber, Wolfgang
2007.
Quality of life and subjective well-being during treatment with antipsychotics in out-patients with schizophrenia.
Progress in Neuro-Psychopharmacology and Biological Psychiatry,
Vol. 31,
Issue. 3,
p.
703.
Novick, Diego
Haro, Josep Maria
Suarez, David
Lambert, Martin
Lépine, Jean-Pierre
and
Naber, Dieter
2007.
Symptomatic remission in previously untreated patients with schizophrenia: 2-year results from the SOHO study.
Psychopharmacology,
Vol. 191,
Issue. 4,
p.
1015.
Haro, Josep Maria
Suarez, David
Novick, Diego
Brown, Jacqueline
Usall, Judith
and
Naber, Dieter
2007.
Three-year antipsychotic effectiveness in the outpatient care of schizophrenia: Observational versus randomized studies results.
European Neuropsychopharmacology,
Vol. 17,
Issue. 4,
p.
235.
Vita, Antonio
Corsini, Paola
Bonomi, Silvia
Cesana, Bruno M.
and
Sacchetti, Emilio
2008.
Factors affecting antipsychotic drug discontinuation in the treatment of schizophrenia: Evidence from a naturalistic, retrospective, 18-month follow-up study.
Schizophrenia Research,
Vol. 104,
Issue. 1-3,
p.
302.
Goudie, AJ
and
Cole, JC
2008.
Switching antipsychotics. Antipsychotic tolerance, withdrawal and relapse: unresolved issues and research implications.
Journal of Psychopharmacology,
Vol. 22,
Issue. 7,
p.
815.
Gasquet, Isabelle
Haro, Josep Maria
Tcherny-Lessenot, Stéphanie
Chartier, Florence
and
Lépine, Jean-Pierre
2008.
Remission in the outpatient care of schizophrenia: 3-Year results from the Schizophrenia Outpatients Health Outcomes (SOHO) Study in France.
European Psychiatry,
Vol. 23,
Issue. 7,
p.
491.
Ciudad, Antonio
Haro, Josep Maria
Alonso, Jordi
Bousoño, Manuel
Suárez, David
Novick, Diego
and
Gilaberte, Inmaculada
2008.
Estudio SOHO (Variables Relacionadas con la Salud en Pacientes Ambulatorios con Esquizofrenia): resultados a los 3 años de la suspensión del tratamiento antipsicótico y factores clínicos relacionados con ella en España.
European psychiatry (Ed. Española),
Vol. 15,
Issue. 3,
p.
137.
Ciudad, Antonio
Haro, Josep María
Alonso, Jordi
Bousoño, Manuel
Suárez, David
Novick, Diego
and
Gilaberte, Inmaculada
2008.
The Schizophrenia Outpatient Health Outcomes (SOHO) study: 3-year results of antipsychotic treatment discontinuation and related clinical factors in Spain.
European Psychiatry,
Vol. 23,
Issue. 1,
p.
1.
Zhu, Baojin
Ascher-Svanum, Haya
Shi, Lizheng
Faries, Douglas
Montgomery, William
and
Marder, Stephen R.
2008.
Time to Discontinuation of Depot and Oral First-Generation Antipsychotics in the Usual Care of Schizophrenia.
Psychiatric Services,
Vol. 59,
Issue. 3,
p.
315.
Ascher-Svanum, Haya
Nyhuis, Allen
Faries, Douglas
Heiler, Lenore
and
Kinon, Bruce
2008.
Treatment Discontinuation Following Randomization to Open-Label Olanzapine, Risperidone or Typical Antipsychotics During a One-Year Treatment for Schizophrenia.
Clinical Schizophrenia & Related Psychoses,
Vol. 2,
Issue. 3,
p.
226.
Novick, Diego
Haro, Josep Maria
Suarez, David
Vieta, Eduard
and
Naber, Dieter
2009.
Recovery in the outpatient setting: 36-month results from the Schizophrenia Outpatients Health Outcomes (SOHO) study.
Schizophrenia Research,
Vol. 108,
Issue. 1-3,
p.
223.
Alonso, Jordi
Croudace, Tim
Brown, Jacqueline
Gasquet, Isabelle
Knapp, Martin R.J.
Suárez, David
and
Novick, Diego
2009.
Health-Related Quality of Life (HRQL) and Continuous Antipsychotic Treatment: 3-year Results from the Schizophrenia Health Outcomes (SOHO) Study.
Value in Health,
Vol. 12,
Issue. 4,
p.
536.
2009.
The Maudsley Prescribing Guidelines, Tenth Edition.
p.
9.
Yu, Andrew P.
Ben-Hamadi, Rym
Birnbaum, Howard G.
Atanasov, Pavel
Stensland, Michael D.
and
Philips, Glenn
2009.
Comparing the treatment patterns of patients with schizophrenia treated with olanzapine and quetiapine in the Pennsylvania Medicaid population.
Current Medical Research and Opinion,
Vol. 25,
Issue. 3,
p.
755.
Se Hyun Kim
Dong Chung Jung
Yong Min Ahn
and
Yong Sik Kim
2010.
The combined use of risperidone long-acting injection and clozapine in patients with schizophrenia non-adherent to clozapine: a case series.
Journal of Psychopharmacology,
Vol. 24,
Issue. 7,
p.
981.
Brnabic, A. J. M.
Kelin, K.
Ascher-Svanum, H.
Montgomery, W.
Kadziola, Z.
and
Karagianis, J.
2011.
Medication discontinuation with depot and oral antipsychotics in outpatients with schizophrenia: comparison of matched cohorts from a 12-month observational study.
International Journal of Clinical Practice,
Vol. 65,
Issue. 9,
p.
945.
Vita, Antonio
Barlati, Stefano
Deste, Giacomo
Corsini, Paola
De Peri, Luca
and
Sacchetti, Emilio
2012.
Factors related to different reasons for antipsychotic drug discontinuation in the treatment of schizophrenia: A naturalistic 18-month follow-up study.
Psychiatry Research,
Vol. 200,
Issue. 2-3,
p.
96.
Kraemer, Susanne
Chartier, Florence
Augendre‐Ferrante, Béatrice
Psarra, Vassiliki
D'yachkova, Yulia
Beselin, Anke
and
Rouillon, Fréderic
2012.
Effectiveness of two formulations of oral olanzapine in patients with schizophrenia or bipolar disorder in a natural setting: results from a 1‐year European observational study.
Human Psychopharmacology: Clinical and Experimental,
Vol. 27,
Issue. 3,
p.
284.
Comments
No Comments have been published for this article.